U87 MG In Vitro Post-translational Modifications Assay
CAT#: ITS-1022-YF409
Target Cell Organism: Human
Target Cell Alternative Name: U87MG; U-87 MG
Target Cell Name: U87 MG
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide U87 MG-based In Vitro Post-translational Modifications Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
U87 MG
Target Cell Organism
Human
Target Cell Background
U-87 MG is a cell line with epithelial morphology that was isolated from malignant gliomas from a male patient, likely with Glioblastoma. Use these cells in your neuroscience and immuno-oncology research.
Target Cell Alternative Name
U87MG; U-87 MG
Related Diseases
Glioblastoma
Research Area
Oncology
Assay Name
In Vitro Post-translational Modifications Assay
Short Description
U87 MG-cell based In Vitro Post-translational Modifications Assay
Assay Description
Immunoassays and mass spectrometry techniques are considered ideal techniques for the detection of post-translational modification. Both the genetic and epigenetic modifications have contributed to the initiation and progression of cancer.
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.